Nicola M. Spirtos

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 367 citations

Tisotumab Vedotin, Cervical Cancer, Metastatic Cervical Cancer +8

Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer

John B. Schlaerth, Nicola M. Spirtos, Alan C. Schlaerth · American Journal of Obstetrics and Gynecology · 2003 · 196 citations

Gynecologic Surgery, Surgical Oncology, Cervical Cancer Management +9

Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study

Paul DiSilvestro, Shamshad Ali, Peter Craighead et al. · Journal of Clinical Oncology · 2014 · 123 citations · Full text

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

Maaike H.M. Oonk, Brian M. Slomovitz, Peter Baldwin et al. · Journal of Clinical Oncology · 2021 · 114 citations · Full text

Laparoscopic Retroperitoneal Lymphadenectomy Followed by Immediate Laparotomy in Women with Cervical Cancer: A Gynecologic Oncology Group Study

John B. Schlaerth, Nicola M. Spirtos, Linda F. Carson et al. · Gynecologic Oncology · 2002 · 102 citations

Gynecologic Surgery, Laparoscopy, Surgical Oncology +7